Ionis appoints C. Frank Bennett, Ph.D., to chief scientific officer and promotes Eric E. Swayze, Ph.D., to senior vice president of research

CARLSBAD, Calif., Dec. 18, 2019 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, today announced the appointments of C. Frank Bennett, Ph.D., as chief scientific officer, and Eric E. Swayze, Ph.D., as senior vice president of research,…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.